Display options
Share it on

PeerJ. 2016 Jan 12;4:e1535. doi: 10.7717/peerj.1535. eCollection 2016.

Fibroblast growth factors as tissue repair and regeneration therapeutics.

PeerJ

Quentin M Nunes, Yong Li, Changye Sun, Tarja K Kinnunen, David G Fernig

Affiliations

  1. Department of Molecular and Clinical Cancer Medicine, NIHR Liverpool Pancreas Biomedical Research Unit, University of Liverpool, Liverpool, United Kingdom.
  2. Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool, United Kingdom.
  3. Department of Biology, School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.

PMID: 26793421 PMCID: PMC4715458 DOI: 10.7717/peerj.1535

Abstract

Cell communication is central to the integration of cell function required for the development and homeostasis of multicellular animals. Proteins are an important currency of cell communication, acting locally (auto-, juxta-, or paracrine) or systemically (endocrine). The fibroblast growth factor (FGF) family contributes to the regulation of virtually all aspects of development and organogenesis, and after birth to tissue maintenance, as well as particular aspects of organism physiology. In the West, oncology has been the focus of translation of FGF research, whereas in China and to an extent Japan a major focus has been to use FGFs in repair and regeneration settings. These differences have their roots in research history and aims. The Chinese drive into biotechnology and the delivery of engineered clinical grade FGFs by a major Chinese research group were important enablers in this respect. The Chinese language clinical literature is not widely accessible. To put this into context, we provide the essential molecular and functional background to the FGF communication system covering FGF ligands, the heparan sulfate and Klotho co-receptors and FGF receptor (FGFR) tyrosine kinases. We then summarise a selection of clinical reports that demonstrate the efficacy of engineered recombinant FGF ligands in treating a wide range of conditions that require tissue repair/regeneration. Alongside, the functional reasons why application of exogenous FGF ligands does not lead to cancers are described. Together, this highlights that the FGF ligands represent a major opportunity for clinical translation that has been largely overlooked in the West.

Keywords: Fibroblast growth factor; Fibroblast growth factor receptor; Healing; Heparan sulfate; Klotho; Protein therapeutic; Tissue repair; Ulcer; Wound

References

  1. Gene. 2001 Jun 27;271(2):171-82 - PubMed
  2. J Biol Chem. 2006 Sep 15;281(37):27178-89 - PubMed
  3. J Cell Sci. 2007 Jun 1;120(Pt 11):1829-32 - PubMed
  4. Cell. 1991 Feb 22;64(4):841-8 - PubMed
  5. J Exp Zool B Mol Dev Evol. 2003 Oct 15;299(1):41-53 - PubMed
  6. J Biol Chem. 2007 Sep 14;282(37):27277-84 - PubMed
  7. Science. 1991 Jun 21;252(5013):1705-8 - PubMed
  8. Otolaryngol Head Neck Surg. 2007 Nov;137(5):757-61 - PubMed
  9. Wound Repair Regen. 2007 Sep-Oct;15(5):617-23 - PubMed
  10. Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3446-50 - PubMed
  11. Neurosurgery. 2005 Mar;56(3):E627; discussion E627 - PubMed
  12. Trends Cell Biol. 2015 Apr;25(4):221-33 - PubMed
  13. J Dent Res. 2011 Jan;90(1):35-40 - PubMed
  14. Mech Dev. 2000 Nov;98(1-2):115-9 - PubMed
  15. Otol Neurotol. 2010 Jan;31(1):118-21 - PubMed
  16. Genes Dev. 1998 May 15;12(10):1425-37 - PubMed
  17. J Bone Miner Res. 2010 Dec;25(12 ):2735-43 - PubMed
  18. BioDrugs. 2008;22(1):37-44 - PubMed
  19. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Nov;116(5):570-5 - PubMed
  20. Bioessays. 2000 Feb;22(2):108-12 - PubMed
  21. Growth Factors. 2014 Oct;32(5):150-4 - PubMed
  22. J Biol Chem. 2014 Apr 4;289(14):10192-200 - PubMed
  23. Yao Xue Xue Bao. 2002 Jun;37(6):424-7 - PubMed
  24. FEBS J. 2010 Oct;277(19):3890-903 - PubMed
  25. Front Biosci. 2008 Jan 01;13:2842-65 - PubMed
  26. Genomics. 2000 Oct 15;69(2):275-9 - PubMed
  27. Mol Cell Proteomics. 2009 Oct;8(10):2256-65 - PubMed
  28. Laryngoscope. 2008 Dec;118(12):2254-9 - PubMed
  29. Nat Rev Mol Cell Biol. 2013 Mar;14(3):166-80 - PubMed
  30. Physiol Rev. 2012 Jan;92(1):131-55 - PubMed
  31. J Biol Chem. 2011 Jun 3;286(22):19892-904 - PubMed
  32. J Biol Chem. 2009 Nov 27;284(48):33030-9 - PubMed
  33. J Biol Chem. 2007 Sep 14;282(37):26687-95 - PubMed
  34. Nature. 1997 Nov 6;390(6655):45-51 - PubMed
  35. Int J Biochem Cell Biol. 2000 Mar;32(3):269-88 - PubMed
  36. Science. 1984 Aug 31;225(4665):932-5 - PubMed
  37. Development. 2003 Aug;130(16):3757-66 - PubMed
  38. Biol Pharm Bull. 2007 Oct;30(10):1819-25 - PubMed
  39. Cancer Metastasis Rev. 2011 Jun;30(2):253-68 - PubMed
  40. FASEB J. 2006 Jan;20(1):9-22 - PubMed
  41. Cell. 1999 Mar 5;96(5):655-65 - PubMed
  42. Cell. 1998 Jan 23;92(2):253-63 - PubMed
  43. J Biol Chem. 2007 Oct 5;282(40):29069-72 - PubMed
  44. FEBS J. 2013 May;280(10):2294-306 - PubMed
  45. J Biol Chem. 2002 Aug 9;277(32):28554-63 - PubMed
  46. Biochim Biophys Acta. 2001 Mar 19;1518(1-2):152-6 - PubMed
  47. Biochem Biophys Res Commun. 1991 Oct 15;180(1):145-51 - PubMed
  48. Oncogene. 1999 Nov 18;18(48):6741-7 - PubMed
  49. J Biol Chem. 2011 Feb 18;286(7):5657-66 - PubMed
  50. Cytokine Growth Factor Rev. 2005 Apr;16(2):215-20 - PubMed
  51. Acta Crystallogr D Biol Crystallogr. 2001 Mar;57(Pt 3):378-84 - PubMed
  52. Development. 1998 Mar;125(6):1083-93 - PubMed
  53. Eur J Dermatol. 2009 Sep-Oct;19(5):461-8 - PubMed
  54. Mol Pharmacol. 2009 Jul;76(1):38-46 - PubMed
  55. Development. 2004 Dec;131(24):6009-21 - PubMed
  56. Proc Natl Acad Sci U S A. 1974 Jul;71(7):2600-4 - PubMed
  57. Clin Otolaryngol. 2013 Aug;38(4):289-96 - PubMed
  58. Development. 2005 Nov;132(21):4857-67 - PubMed
  59. Open Biol. 2015 Aug;5(8):null - PubMed
  60. Proc Natl Acad Sci U S A. 1988 Apr;85(7):2324-8 - PubMed
  61. Adv Exp Med Biol. 2012;728:25-40 - PubMed
  62. Plast Reconstr Surg Glob Open. 2015 May 07;3(4):e371 - PubMed
  63. Laryngoscope. 2012 Feb;122(2):327-31 - PubMed
  64. Science. 1993 Mar 26;259(5103):1918-21 - PubMed
  65. Dev Biol. 2003 Jun 1;258(1):185-200 - PubMed
  66. Curr Biol. 2010 Nov 23;20(22):2021-7 - PubMed
  67. Wound Repair Regen. 2008 Sep-Oct;16(5):635-41 - PubMed
  68. Cell. 1995 Nov 17;83(4):611-20 - PubMed
  69. Trends Genet. 2004 Nov;20(11):563-9 - PubMed
  70. PLoS Biol. 2012 Jul;10(7):e1001361 - PubMed
  71. Science. 2005 Oct 21;310(5747):490-3 - PubMed
  72. Science. 1991 Jan 4;251(4989):90-3 - PubMed
  73. Drug Discov Today. 2014 May;19(5):579-89 - PubMed
  74. FEBS J. 2013 May;280(10):2260-70 - PubMed
  75. Eur Cell Mater. 2012 Jul 24;24:107-16; discussion 116-7 - PubMed
  76. Heart Vessels. 2016 May;31(5):713-21 - PubMed
  77. J Cell Physiol. 2008 Apr;215(1):1-7 - PubMed
  78. J Biol Chem. 2006 Mar 10;281(10):6120-3 - PubMed
  79. Curr Opin Investig Drugs. 2009 Apr;10(4):359-64 - PubMed
  80. Int J Cancer. 1996 Jan 3;65(1):104-11 - PubMed
  81. J Mammary Gland Biol Neoplasia. 2001 Jul;6(3):253-73 - PubMed
  82. Nat Rev Cancer. 2010 Feb;10(2):116-29 - PubMed
  83. Prog Growth Factor Res. 1994;5(4):353-77 - PubMed
  84. Clin Sci (Lond). 2014 Aug;127(4):217-31 - PubMed
  85. J R Soc Interface. 2007 Jun 22;4(14):413-37 - PubMed
  86. Bone Marrow Transplant. 2013 Jan;48(1):99-104 - PubMed
  87. Nature. 2014 Sep 18;513(7518):436-9 - PubMed
  88. Neuron. 2004 May 13;42(3):367-74 - PubMed
  89. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2433-7 - PubMed
  90. Cochrane Database Syst Rev. 2011 Apr 13;(4):CD000978 - PubMed
  91. Biochemistry. 1994 Sep 13;33(36):10999-1007 - PubMed
  92. Nat Med. 1998 Jun;4(6):691-7 - PubMed
  93. Front Biosci. 2008 May 01;13:4309-38 - PubMed
  94. J Biol Chem. 2004 Jun 25;279(26):27239-45 - PubMed
  95. Int J Exp Pathol. 2015 Aug;96(4):203-31 - PubMed
  96. Development. 2010 Nov;137(22):3731-42 - PubMed
  97. J Cell Physiol. 1989 Jul;140(1):68-74 - PubMed
  98. J Biol Chem. 1996 Jun 21;271(25):15292-7 - PubMed
  99. Biochemistry. 1994 Apr 5;33(13):3831-40 - PubMed
  100. Trends Cell Biol. 2001 Feb;11(2):75-82 - PubMed
  101. J Biol Chem. 2012 Nov 16;287(47):40061-73 - PubMed
  102. Annu Rev Biochem. 2014;83:129-57 - PubMed
  103. Ann Surg. 1992 Oct;216(4):401-6; discussion 406-8 - PubMed
  104. Nat Rev Drug Discov. 2009 Mar;8(3):235-53 - PubMed
  105. An Acad Bras Cienc. 2009 Sep;81(3):409-29 - PubMed
  106. Development. 2004 Jun;131(11):2595-604 - PubMed
  107. Front Immunol. 2013 Nov 20;4:385 - PubMed
  108. Dev Dyn. 2009 Feb;238(2):277-93 - PubMed
  109. Br J Cancer. 1994 Apr;69(4):772-6 - PubMed
  110. Mol Cell. 2000 Sep;6(3):743-50 - PubMed
  111. Plast Reconstr Surg. 1989 Nov;84(5):827-37 - PubMed
  112. Science. 1984 Mar 23;223(4642):1296-9 - PubMed
  113. Dev Biol. 2008 Jun 15;318(2):268-75 - PubMed
  114. J Biochem. 2011 Feb;149(2):121-30 - PubMed
  115. Annu Rev Biochem. 1989;58:575-606 - PubMed
  116. Cancer. 2006 Jan 15;106(2):329-36 - PubMed
  117. J Biol Chem. 1992 May 15;267(14):9451-4 - PubMed
  118. Mol Cell Neurosci. 1996;8(2-3):99-111 - PubMed
  119. Mol Biol Cell. 1997 Dec;8(12 ):2449-61 - PubMed
  120. Perit Dial Int. 2007 Jun;27 Suppl 2:S104-9 - PubMed
  121. Cold Spring Harb Perspect Biol. 2013 Jun 01;5(6):null - PubMed
  122. Dev Dyn. 2008 Jan;237(1):18-27 - PubMed
  123. J Biol Chem. 2006 Jun 9;281(23):15694-700 - PubMed
  124. Nature. 2006 Dec 7;444(7120):770-4 - PubMed
  125. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2292-6 - PubMed
  126. Science. 1996 Feb 23;271(5252):1116-20 - PubMed
  127. Arthritis Rheumatol. 2014 Jul;66(7):1820-31 - PubMed

Publication Types